Navigation Links
Basic research leads to a novel cancer therapy

cancer development. The Max Planck scientists showed that tumour tissue just a few cubic millimetres in size can create vascular endothelial growth factor (VEGF), which triggers blood vessel development.

Ullrich found some of the most important evidence in research on animals, conducted with colleagues Birgit Millauer and the late Werner Risau, formerly of the Max Planck Institute of Neurobiology. There is a receptor specific to VEGF, called Flk-1/VEGFR2, found only in endothelial cells which are the building stones of new blood vessels. When Flk-1/VEGFR2 is made inoperative, this blocks the development of tumours. If no blood vessels are created in tumour tissue, the tumour fails to grow. This discovery led to the invention of what are called angiogenesis inhibitors (angiogenesis is the process of blood vessel formation).

Ullrich and the Max Planck Society, in co-operation with New York University, founded SUGEN, Inc. in California in 1991. SUGEN is the first biotechnology company with roots in the Max Planck Society. The firm developed chemical substances which block Flk-1/VEGFR2 in endothelial cells. At the end of the 1990s SUGEN was taken over by Pharmacia, which itself was bought by Pfizer in 2003. Development of the project continued at Pfizer. SUTENT® (active ingredient Sunitinib) has now reached the market as a multi-targeted tyrosine kinase inhibitor, which blocks both the building of blood vessels in tumours as well as other illness-related enzymes in tumour cell signalling networks.

Clinical studies with GIST patients looked into their ability to tolerate Sunitinib, as well as its effectiveness on them. Some of these patients had already been treated with Imatinib, but their tumours continued to develop. Others were not able to tolerate Imatinib at all. Still other patients had advanced renal cell carcinoma with failed available treatment. In the case of the GIST patients, it took four times longer for tumours to renew growth when
'"/>

Source:Max-Planck-Gesellschaft


Page: 1 2 3 4

Related biology news :

1. Distributed Basic Local Alignment Search Toolkit (W.ND-BLAST)
2. Basic work on E. coli identifies two new keys to regulation of bacterial gene expression
3. Columbia research lifts major hurdle to gene therapy for cancer
4. U of M researcher examines newly emerging deadly disease
5. NYU researchers simulate molecular biological clock
6. First atlas of key brain genes could speed research on cancer, neurological diseases
7. New research questions basic tenet of neuron function
8. Vital step in cellular migration described by UCSD medical researchers
9. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
10. UCSD researchers maintain stem cells without contaminated animal feeder layers
11. Why do insects stop breathing? To avoid damage from too much oxygen, say researchers

Post Your Comments:
(Date:11/30/2009)...to rise scientists are presented with the complex ... adapt. In a paper published in Insect Conservati...and Dr Miguel Rodriguez assess this challenge. , ... 0.6˚C has already affected the Earth,s biota... evolutionary biologists is to predict how biologi...
(Date:11/30/2009)...in the December 2009 print issue of The FASEB Jou...ol over their fertility that women have had since ...w and where androgenic hormones work in the testis...lity. This opens a promising avenue for the develo...fers hope to those who cannot have children becaus...
(Date:11/26/2009)...ers, red deer have been caught in the hunters, sig... more than decorative. They are lethal weapons tha... from The University of York, UK, has been intrigu...alf a century and has become fascinated by the mec...ng collaboration with Tomas Landete-Castillejos at...
Breaking Biology News(10 mins):How can scientists measure evolutionary responses to climate change? 2Tough yet stiff deer antler is materials scientist's dream 2And the Beat Goes on 55659 1And the Beat Goes on 55659 2Think zinc 3A Molecular sensor could reveal zincs role in diseases 9732 1Think zinc 3A Molecular sensor could reveal zincs role in diseases 9732 2Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 1Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 2Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 3Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 4Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 5Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 6Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 7Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 8Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 9
...est assured that when you,re asleep they are too. ...9 issue of the journal GENETICS ( http://www.gen...souri-Kansas City have shown that the circadian rh...brates are regulated by some of the same "cellular...ficant because the sleep-regulating enzyme analyze...
...ion to the state of the snow on the slopes, there ...looking closely at a South Pole snowfield this Jan...ted by the UK,s National Physical Laboratory (NPL)... as part of the world,s largest inter-comparison b...ow scientists to fully quantify differences betwee...
...xas is up for a new name, based on Southern Method...r has been misidentified. , State Rep. Charles Ge...nge the name of the state dinosaur from Pleurocoe...e massive sauropod ,whose tracks and bones litter ...scientist behind the name change: His master,s lev...
Other Biology News:When it comes to sleep research, fruit flies and people make unlikely bedfellows 2Satellites search out South Pole snowfields 2A case of mistaken dino-identity 2
(Date:11/30/2009)...ov. 30 Dr. Jessica Torrente, Assis...niversity Medical Center in Washington, D.C., demo...c Gamma Imaging (BSGI) in clinical practice as an ...st cancer today at the annual meeting of the Radio...e purpose of the exhibit was to demonstrate how BS...
(Date:11/30/2009)...TTLE, Nov. 30 Cell Thera...ed today that its new class of platinum-based anti...ted a stronger anti-tumor potency and activity com...nds as well as the ability to overcome cisplatin-r...presented in a paper titled "Novel Bis-platinum Co...
(Date:11/29/2009)...ailable in German . , The concept of confin...s. The most famous example is that of quarks which...rof. Bella Lake from Helmholtz-Zentrum Berlin toge...rt for the first time an experimental realization ...a condensed matter system. , The concept of conf...
(Date:11/26/2009)... Ind. - A new generation of ultrasmall transistors...tures called semiconducting nanowires are closer t...IBM, Purdue University and the University of Calif...rned how to create nanowires with layers of differ...ic level, which is a critical requirement for maki...
Breaking Biology Technology:Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3Spinons -- confined like quarks 2Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3
... Sangamo,BioSciences, Inc. (Nasdaq: SGMO ) announ... and CEO, will provide an update on the progress o...nd an overview of the,company,s business strategy ...t the 2008 UBS Global Life Sciences Conference in ...live and may be accessed via a link on,the Sangamo...
...6 Nektar,Therapeutics, (Nasdaq: NKTR ) President...scheduled to present at the upcoming UBS 2008 Glob...nd Hyatt New York Hotel on,Tuesday, September 23, ...accessible via a Webcast through a link posted,on ... the Nektar website:, http://www.nektar.com . This...
... http://www.amdl.com ) AMDL, Inc. (Amex: ADL ), a... major operations in China and the US, announced,t...000 private placement,offering of 10% convertible ...Jesup & Lamont Securities Corporation and Dawson J...and CEO of AMDL, Inc., said, "This financing,stren...
Other Biology Technology:Sangamo BioSciences to Present at the UBS Global Life Sciences Conference 2AMDL, Inc. Closes Private Placement of Convertible Notes 2AMDL, Inc. Closes Private Placement of Convertible Notes 3AMDL, Inc. Closes Private Placement of Convertible Notes 4
GENOMIPHI HY KIT 1000 RXN from GE Healthcare, formerly Amersham Biosciences
N-terminal Sequencing from Primm Biotech, Inc.
Japanese medaka Vitellogenin Standard from Cayman Chemical
I-SAGE Ditag PCR Module* from Invitrogen
Biology Products: